|
Volumn 29, Issue 3, 1999, Pages 924-927
|
Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B CORE ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
PLACEBO;
RECOMBINANT VACCINE;
ANTIBODY TITER;
ANTIGEN ANTIBODY COMPLEX;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HUMAN;
IMMUNITY;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
VACCINATION;
|
EID: 0033020623
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510290327 Document Type: Article |
Times cited : (69)
|
References (9)
|